Sara Quenet

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Delphine Réa, Michael J. Mauro, Carla Boquimpani et al. · Blood · 2021 · 336 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism

Patrick Mismetti, Karine Rivron-Guillot, Sara Quenet et al. · CHEST Journal · 2007 · 144 citations

Medicine, Surgery, Vascular Surgery +7

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL

Andreas Hochhaus, Delphine Réa, Carla Boquimpani et al. · Leukemia · 2023 · 135 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Comparison of the clinical history of symptomatic isolated distal deep‐vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients

J.‐P. Galanaud, Sara Quenet, Karine Rivron-Guillot et al. · Journal of Thrombosis and Haemostasis · 2009 · 128 citations · Full text

Medicine, Internal Medicine, Surgery +11

Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays

Claire Flaujac, Xavier Delavenne, Sara Quenet et al. · Thrombosis and Haemostasis · 2013 · 112 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +14